|
🐜
|
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
22 auth.
P. Sperduto,
N. Kased,
D. Roberge,
Zhiyuan Xu,
R. Shanley,
Xianghua Luo,
P. Sneed,
S. Chao,
R. Weil,
J. Suh,
...
A. Bhatt,
A. Jensen,
P. Brown,
H. Shih,
J. Kirkpatrick,
L. Gaspar,
J. Fiveash,
V. Chiang,
J. Knisely,
C. M. Sperduto,
N. Lin,
M. Mehta
|
10 |
2012 |
10
🐜
|
|
🐜
|
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.
18 auth.
P. Sperduto,
S. Chao,
P. Sneed,
Xianghua Luo,
J. Suh,
D. Roberge,
A. Bhatt,
A. Jensen,
P. Brown,
H. Shih,
...
J. Kirkpatrick,
A. Schwer,
L. Gaspar,
J. Fiveash,
V. Chiang,
J. Knisely,
C. M. Sperduto,
M. Mehta
|
9 |
2009 |
9
🐜
|
|
🐢
|
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
22 auth.
P. Brown,
P. Brown,
K. Ballman,
K. Ballman,
J. Cerhan,
S. K. Anderson,
X. Carrero,
A. Whitton,
J. Greenspoon,
I. Parney,
...
N. Laack,
J. Ashman,
J. Bahary,
C. Hadjipanayis,
J. Urbanic,
F. Barker,
E. Farace,
D. Khuntia,
C. Giannini,
J. Buckner,
E. Galanis,
D. Roberge
|
9 |
2017 |
9
🐢
|
|
🐜
|
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
14 auth.
P. Brown,
S. Pugh,
N. Laack,
J. Wefel,
D. Khuntia,
C. Meyers,
A. Choucair,
S. Fox,
J. Suh,
D. Roberge,
...
V. Kavadi,
S. Bentzen,
M. Mehta,
D. Watkins-Bruner
|
9 |
2013 |
9
🐜
|
|
🐜
|
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
27 auth.
P. Sperduto,
T. Yang,
K. Beal,
Hubert Y. Pan,
P. Brown,
A. Bangdiwala,
R. Shanley,
Norman Yeh,
L. Gaspar,
S. Braunstein,
P. Sneed,
J. Boyle,
J. Kirkpatrick,
K. Mak,
H. Shih,
...
A. Engelman,
D. Roberge,
Nils D. Arvold,
B. Alexander,
M. Awad,
J. Contessa,
V. Chiang,
J. Hardie,
D. Ma,
E. Lou,
W. Sperduto,
M. Mehta
|
9 |
2017 |
9
🐜
|
|
🐜
|
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
30 auth.
P. Brown,
V. Gondi,
S. Pugh,
W. Tomé,
J. Wefel,
T. Armstrong,
J. Bovi,
C. Robinson,
A. Konski,
D. Khuntia,
D. Grosshans,
T. Benzinger,
D. Bruner,
M. Gilbert,
D. Roberge,
...
V. Kundapur,
K. Devisetty,
Sunjay A. Shah,
K. Usuki,
B. Anderson,
B. Stea,
H. Yoon,
Jing Li,
N. Laack,
T. Kruser,
S. Chmura,
W. Shi,
S. Deshmukh,
M. Mehta,
L. Kachnic
|
9 |
2020 |
9
🐜
|
|
🐜
|
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.
22 auth.
P. Sperduto,
N. Kased,
D. Roberge,
Zhiyuan Xu,
R. Shanley,
Xianghua Luo,
P. Sneed,
S. Chao,
R. Weil,
J. Suh,
...
A. Bhatt,
A. Jensen,
P. Brown,
H. Shih,
J. Kirkpatrick,
L. Gaspar,
J. Fiveash,
V. Chiang,
J. Knisely,
C. M. Sperduto,
N. Lin,
M. Mehta
|
8 |
2012 |
8
🐜
|
|
🐜
|
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
12 auth.
M. Robson,
P. Chappuis,
J. Satagopan,
N. Wong,
J. Boyd,
J. Goffin,
...
C. Hudis,
D. Roberge,
L. Norton,
L. Bégin,
K. Offit,
W. Foulkes
|
8 |
2003 |
8
🐜
|
|
🐜
|
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.
39 auth.
P. Sperduto,
S. Mesko,
Jing Li,
D. Cagney,
A. Aizer,
N. Lin,
E. Nesbit,
T. Kruser,
J. Chan,
S. Braunstein,
Jessica Lee,
J. Kirkpatrick,
W. Breen,
P. Brown,
D. Shi,
...
H. Shih,
H. Soliman,
A. Sahgal,
R. Shanley,
W. Sperduto,
E. Lou,
A. Everett,
D. Boggs,
L. Masucci,
D. Roberge,
J. Remick,
K. Plichta,
J. Buatti,
Supriya K. Jain,
L. Gaspar,
Cheng-Chia Wu,
T. Wang,
J. Bryant,
M. Chuong,
Y. An,
V. Chiang,
Toshimichi Nakano,
H. Aoyama,
M. Mehta
|
8 |
2020 |
8
🐜
|
|
🐜
|
The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy.
16 auth.
A. Sahgal,
A. Sahgal,
D. Roberge,
D. Schellenberg,
T. Purdie,
A. Swaminath,
J. Pantarotto,
E. Filion,
Z. Gabos,
J. Butler,
...
D. Létourneau,
G. Masucci,
L. Mulroy,
A. Bezjak,
L. Dawson,
M. Parliament
|
7 |
2012 |
7
🐜
|
|
🐜
|
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).
23 auth.
P. Sperduto,
Wen Jiang,
P. Brown,
S. Braunstein,
P. Sneed,
D. Wattson,
H. Shih,
A. Bangdiwala,
R. Shanley,
N. Lockney,
...
K. Beal,
E. Lou,
T. Amatruda,
W. Sperduto,
J. Kirkpatrick,
Norman Yeh,
L. Gaspar,
J. Molitoris,
L. Masucci,
D. Roberge,
James B. Yu,
V. Chiang,
M. Mehta
|
7 |
2017 |
7
🐜
|
|
🐜
|
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer
20 auth.
P. Sperduto,
N. Kased,
D. Roberge,
S. Chao,
R. Shanley,
Xianghua Luo,
P. Sneed,
J. Suh,
R. Weil,
A. Jensen,
...
P. Brown,
H. Shih,
J. Kirkpatrick,
L. Gaspar,
J. Fiveash,
V. Chiang,
J. Knisely,
C. M. Sperduto,
N. Lin,
M. Mehta
|
7 |
2013 |
7
🐜
|
